Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population

Table 1

Subjects’ clinical characteristics.

Characteristics	Median (range) or %	Number or count/available
Intended population	70.4	57
Age	65 (54–80)	57
Prebiopsy serum PSA (ng/ml)	9.59 (1.08–19.45)	57
1–10 ng/ml	59.6	34/57
10–20 ng/ml	40.4	23/57
Suspicious DRE	30	11/37
No prior biopsy	91.2	52/57
Number of cores	10	57
Positive biopsy result	24.6	14/57
Gleason score
GS = 6 (3 + 3)	10.5	6/57
GS ≥ 7	14.03	8/57
GS = 7 (3 + 4)	3.5	2/57
GS = 7 (4 + 3)	5.3	3/57
GS = 9 (5 + 4)	1.8	1/57
GS = 10 (5 + 5)	3.5	2/57